MedPath
NMPA Approval

Sugammadex Sodium Injection

国药准字H20243562

April 24, 2024

Drug Information

舒更葡糖钠注射液

注射剂

按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg

化学药品

April 24, 2024

Company Information

Applicant Company

泰州市健康大道801号28幢

Manufacturing Company

苏州市木渎镇花苑东路199号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

舒更葡糖钠注射液 - NMPA 批准文号 | MedPath